Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.29 USD | -6.83% | -25.40% | +31.95% |
04/06 | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
24/05 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.95% | 486M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Cartesian Gets Regenerative Medicine Advanced Therapy Label for Myasthenia Gravis Drug Candidate